Katie Price, the British media personality, author, and former glamour model, has built a career in the public eye. Known for her candidness about her personal life, including her struggles as a mother and her health challenges, Price has remained a prominent figure in British pop culture for over two decades. Now, she is in the spotlight for a deeply personal reason: her son Harvey’s health.
Price has revealed that her 23-year-old son, Harvey, who weighs 28 stone, will soon begin a new weight-loss drug. Doctors have advised that medication may be necessary to protect his health.
Harvey, who has a complex medical history, has long struggled with his weight. He is blind, lives with autism, and has septo-optic dysplasia. He also has Prader-Willi syndrome, a rare genetic condition that causes constant hunger and increases the risk of obesity.
Price explained that despite careful dietary management and support, Harvey’s weight has remained dangerously high. At 28 stone, his size has begun to affect his mobility and daily life. Simple tasks, such as walking or even putting on shoes, have become increasingly challenging.
“The doctors are very concerned,” Price said. “They think it’s the only way to help him now.” She revealed that Harvey could soon start a new medication, which has shown promising results in clinical trials. The treatment is still in early stages, but it is expected to be made available to patients with urgent medical needs.
The plan, she explained, is for Harvey to start with an established drug for weight management, then transition to the newer treatment once it becomes accessible. “It’s a step-by-step process,” Price said. “We are hoping it will give him a better, longer life.”
This announcement comes amid growing worries about Harvey’s health. Earlier this year, Price admitted that she feared he could face serious complications, including a potential heart attack. His weight and underlying medical conditions put him at significant risk, making intervention urgent.
For Price, this has been an emotional journey. She has been closely involved in Harvey’s care for years, managing his diet, appointments, and daily routines. Despite her dedication, she acknowledges that medication may be the only way to make meaningful progress.
“I’ve tried everything,” she said. “Food plans, dietitians, exercise… but his condition makes it very hard. We’re doing this for him, to keep him safe and healthy.”
Medical experts hope the new treatment will help Harvey manage his weight more effectively. Early trials suggest that it can significantly reduce body weight in patients with obesity, especially when combined with dietary support.
While the exact timeline for starting the drug is not yet confirmed, Price said she is optimistic. She hopes that the medication, along with continued support, will improve Harvey’s quality of life and allow him to be more independent.
Harvey’s case highlights the challenges faced by individuals with complex medical conditions. Prader-Willi syndrome, in particular, makes weight management exceptionally difficult. Constant hunger and a slower metabolism mean that traditional diet and exercise plans often have limited effect.
For families like the Prices, new medical treatments offer hope. They provide a tool to manage weight and reduce the risk of serious health complications. For Harvey, this could mean greater mobility, fewer health risks, and an improved daily life.
Katie Price remains committed to supporting her son through this process. She hopes that sharing Harvey’s story will raise awareness about the difficulties faced by people with Prader-Willi syndrome and obesity.
“Every step we take is for Harvey,” she said. “We just want him to live a long, happy, healthy life.”
With the potential new treatment on the horizon, there is cautious optimism for Harvey’s future. Doctors, parents, and caregivers alike hope that this intervention will be a turning point, offering both hope and tangible results in the ongoing struggle against obesity.
